Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
1999
|